|
1
|
Ostrom QT, Price M, Neff C, Cioffi G,
Waite KA, Kruchko C and Barnholtz-Sloan JS: CBTRUS statistical
report: Primary brain and other central nervous system tumors
diagnosed in the United States in 2015–2019. Neuro Oncol. 24 (Suppl
5):S1–S95. 2022. View Article : Google Scholar
|
|
2
|
Wesseling P and Capper D: WHO 2016
classification of gliomas. Neuropathol Appl Neurobiol. 44:139–150.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xu S, Tang L, Li X, Fan F and Liu Z:
Immunotherapy for glioma: Current management and future
application. Cancer Letters. 476:1–12. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wen J, Chen W, Zhu Y and Zhang P: Clinical
features associated with the efficacy of chemotherapy in patients
with glioblastoma (GBM): A surveillance, epidemiology, and end
results (SEER) analysis. BMC Cancer. 21:812021. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tan AC, Ashley DM, López GY, Malinzak M,
Friedman HS and Khasraw M: Management of glioblastoma: State of the
art and future directions. CA Cancer J Clin. 70:299–312. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ramón Y, Cajal S, Sesé M, Capdevila C,
Aasen T, De Mattos-Arruda L, Diaz-Cano SJ, Hernández-Losa J and
Castellví J: Clinical implications of intratumor heterogeneity:
Challenges and opportunities. J Mol Med (Berl). 98:161–177. 2020.
View Article : Google Scholar
|
|
7
|
Binder DC, Ladomersky E, Lenzen A, Zhai L,
Lauing KL, Otto-Meyer SD, Lukas RV and Wainwright DA: Lessons
learned from rindopepimut treatment in patients with
EGFRvIII-expressing glioblastoma. Transl Cancer Res. 7 (Suppl
4):S510–S513. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wick W, Gorlia T, Bendszus M, Taphoorn M,
Sahm F, Harting I, Brandes AA, Taal W, Domont J, Idbaih A, et al:
Lomustine and bevacizumab in progressive glioblastoma. N Engl J
Med. 377:1954–1963. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
de la Fuente MI, Colman H, Rosenthal M,
Van Tine BA, Levacic D, Walbert T, Gan HK, Vieito M, Milhem MM,
Lipford K, et al: Olutasidenib (FT-2102) in patients with relapsed
or refractory IDH1-mutant glioma: A multicenter, open-label, phase
Ib/II trial. Neuro Oncol. 25:146–156. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bale TA and Rosenblum MK: The 2021 WHO
classification of tumors of the central nervous system: An update
on pediatric low-grade gliomas and glioneuronal tumors. Brain
Pathol. 32:e130602022. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gonzalez LL, Garrie K and Turner MD: Role
of S100 proteins in health and disease. Biochim Biophys Acta Mol
Cell Res. 1867:1186772020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li Z, Tang M, Ling B, Liu S, Zheng Y, Nie
C, Yuan Z, Zhou L, Guo G, Tong A and Wei Y: Increased expression of
S100A6 promotes cell proliferation and migration in human
hepatocellular carcinoma. J Mol Med (Berl). 92:291–303. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li Y, Wagner ER, Yan Z, Wang Z, Luther G,
Jiang W, Ye J, Wei Q, Wang J, Zhao L, et al: The calcium-binding
protein S100A6 accelerates human osteosarcoma growth by promoting
cell proliferation and inhibiting osteogenic differentiation. Cell
Physiol Biochem. 37:2375–2392. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen X, Liu X, Lang H, Zhang S, Luo Y and
Zhang J: S100 calcium-binding protein A6 promotes
epithelial-mesenchymal transition through β-catenin in pancreatic
cancer cell line. PLoS One. 10:e01213192015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang XH, Zhang LH, Zhong XY, Xing XF, Liu
YQ, Niu ZJ, Peng Y, Du H, Zhang GG, Hu Y, et al: S100A6
overexpression is associated with poor prognosis and is
epigenetically up-regulated in gastric cancer. Am J Pathol.
177:586–597. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li L, Pan Y, Mo X, Wei T, Song J, Luo M,
Huang G, Teng C, Liang K, Mao N and Yang J: A novel metastatic
promoter CEMIP and its downstream molecular targets and signaling
pathway of cellular migration and invasion in SCLC cells based on
proteome analysis. J Cancer Res Clin Oncol. 146:2519–2534. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Camby I, Nagy N, Lopes MB, Schäfer BW,
Maurage CA, Ruchoux MM, Murmann P, Pochet R, Heizmann CW, Brotchi
J, et al: Supratentorial pilocytic astrocytomas, astrocytomas,
anaplastic astrocytomas and glioblastomas are characterized by a
differential expression of S100 proteins. Brain Pathol. 9:1–19.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Camby I, Lefranc F, Titeca G, Neuci S,
Fastrez M, Dedecken L, Schäfer BW, Brotchi J, Heizmann CW, Pochet
R, et al: Differential expression of S100 calcium-binding proteins
characterizes distinct clinical entities in both WHO grade II and
III astrocytic tumours. Neuropathol Appl Neurobiol. 26:76–90. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kucharczak J, Pannequin J, Camby I,
Decaestecker C, Kiss R and Martinez J: Gastrin induces
over-expression of genes involved in human U373 glioblastoma cell
migration. Oncogene. 20:7021–7028. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang Y, Yang X, Zhu XL, Bai H, Wang ZZ,
Zhang JJ, Hao CY and Duan HB: S100A gene family: Immune-related
prognostic biomarkers and therapeutic targets for low-grade glioma.
Aging (Albany NY). 13:15459–15478. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Blum A, Wang P and Zenklusen JC: SnapShot:
TCGA-analyzed tumors. Cell. 173:5302018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chin L, Hahn WC, Getz G and Meyerson M:
Making sense of cancer genomic data. Genes Dev. 25:534–555. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Grossman RL, Heath AP, Ferretti V, Varmus
HE, Lowy DR, Kibbe WA and Staudt LM: Toward a shared vision for
cancer genomic data. N Engl J Med. 75:1109–1112. 2016. View Article : Google Scholar
|
|
24
|
Ceccarelli M, Barthel FP, Malta TM,
Sabedot TS, Salama SR, Murray BA, Morozova O, Newton Y, Radenbaugh
A, Pagnotta SM, et al: Molecular profiling reveals biologically
discrete subsets and pathways of progression in diffuse glioma.
Cell. 164:550–663. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Love MI, Huber W and Anders S: Moderated
estimation of fold change and dispersion for RNA-seq data with
DESeq2. Genome Biol. 15:5502014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yan X, Hong B, Feng J, Jin Y, Chen M, Li F
and Qian Y: B7-H4 is a potential diagnostic and prognostic
biomarker in colorectal cancer and correlates with the
epithelial-mesenchymal transition. BMC Cancer. 22:10532022.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fan W, Song Y, Ren Z, Cheng X, Li P, Song
H and Jia L: Glioma cells are resistant to inflammation-induced
alterations of mitochondrial dynamics. Int J Oncol. 57:1293–1306.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu J, Lichtenberg T, Hoadley KA, Poisson
LM, Lazar AJ, Cherniack AD, Kovatich AJ, Benz CC, Levine DA, Lee
AV, et al: An integrated TCGA pan-cancer clinical data resource to
drive high-quality survival outcome analytics. Cell.
173:400–416.e411. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yu CH: Evaluation of diagnostic test,
Medical statistics. Beijing: People's Medical Publishing House; pp.
164–178. 2002, (In Chinese).
|
|
30
|
Radin DP and Tsirka SE: Interactions
between tumor cells, neurons, and microglia in the glioma
microenvironment. Int J Mol Sci. 21:84762020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Barthel L, Hadamitzky M, Dammann P,
Schedlowski M, Sure U, Thakur BK and Hetze S: Glioma: molecular
signature and crossroads with tumor microenvironment. Cancer
Metastasis Rev. 41:53–75. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Filipek A and Leśniak W: S100A6 and its
brain ligands in neurodegenerative disorders. Int J Mol Sci.
21:39792020. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Donato R, Sorci G and Giambanco I: S100a6
protein: functional roles. Cell Mol Life Sci. 74:2749–2760. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hua X, Zhang H, Jia J, Chen S, Sun Y and
Zhu X: Roles of S100 family members in drug resistance in tumors:
Status and prospects. BioMed Pharmacother. 127:1101562020.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hu Y, Zeng N, Ge Y, Wang D, Qin X, Zhang
W, Jiang F and Liu Y: Identification of the shared gene signatures
and biological mechanism in type 2 diabetes and pancreatic cancer.
Front Endocrinol (Lausanne). 13:8477602022. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhao J, Huang Y, Song Y, Xie D, Hu M, Qiu
H and Chu J: Diagnostic accuracy and potential covariates for
machine learning to identify IDH mutations in glioma patients:
Evidence from a meta-analysis. Eur Radiol. 30:4664–4674. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ghouzlani A, Kandoussi S, Tall M, Reddy
KP, Rafii S and Badou A: Immune checkpoint inhibitors in human
glioma microenvironment. Front Immunol. 12:6794252021. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lapointe S, Perry A and Butowski NA:
Primary brain tumours in adults. Lancet. 392:432–446. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wirths O, Breyhan H, Marcello A, Cotel MC,
Bruck W and Bayer TA: Inflammatory changes are tightly associated
with neurodegeneration in the brain and spinal cord of the
APP/PS1KI mouse model of Alzheimer's disease. Neurobiol Aging.
31:747–757. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tong H, Wang L, Zhang K, Shi J, Wu Y, Bao
Y and Wang C: Correction to: S100A6 activates kupffer cells via the
p-P38 and p-JNK pathways to induce inflammation,
mononuclear/macrophage infiltration sterile liver injury in mice.
Inflammation. 46:5552023. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Liu Z, Zhang X, Chen M, Cao Q and Huang D:
Effect of S100A6 over-expression on beta-catenin in endometriosis.
J Obstet Gynaecol Res. 41:1457–1462. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Rijsewijk F, van Deemter L, Wagenaar E,
Sonnenberg A and Nusse R: Transfection of the int-1 mammary
oncogene in cuboidal RAC mammary cell line results in morphological
transformation and tumorigenicity. EMBO J. 6:127–131. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Deberardinis RJ: Tumor microenvironment,
metabolism, and immunotherapy. N Engl J Med. 382:869–871. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Chen F, Song J, Ye Z, Xu B, Cheng H, Zhang
S and Sun X: Integrated analysis of cell cycle-related and
immunity-related biomarker signatures to improve the prognosis
prediction of lung adenocarcinoma. Front Oncol. 11:6668262021.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Li C, Jiang P, Wei S, Xu X and Wang J:
Regulatory T cells in tumor microenvironment: New mechanisms,
potential therapeutic strategies and future prospects. Mol Cancer.
19:1162020. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Erin N, Grahovac J, Brozovic A and Efferth
T: Tumor microenvironment and epithelial mesenchymal transition as
targets to overcome tumor multidrug resistance. Drug Resist Update.
53:1007152020. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wei J, Chen P, Gupta P, Ott M, Zamler D,
Kassab C, Bhat KP, Curran MA, de Groot JF and Heimberger AB: Immune
biology of glioma-associated macrophages and microglia: Functional
and therapeutic implications. Neuro Oncol. 22:180–194.
2020.PubMed/NCBI
|
|
48
|
Xia Y, Rao L, Yao H, Wang Z, Ning P and
Chen X: Engineering macrophages for cancer immunotherapy and drug
delivery. Adv Mater. 32:e20020542020. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Hambardzumyan D, Gutmann DH and Kettenmann
H: The role of microglia and macrophages in glioma maintenance and
progression. Nat Neurosci. 19:20–27. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Domingues P, González-Tablas M, Otero Á,
Pascual D, Miranda D, Ruiz L, Sousa P, Ciudad J, Gonçalves JM,
Lopes MC, et al: Tumor infiltrating immune cells in gliomas and
meningiomas. Brain Behav Immun. 53:1–15. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Di W, Fan W, Wu F, Shi Z, Wang Z, Yu M,
Zhai Y, Chang Y, Pan C, Li G, et al: Clinical characterization and
immunosuppressive regulation of CD161 (KLRB1) in glioma through 916
samples. Cancer Sci. 113:756–769. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Cho A, McKelvey KJ, Lee A and Hudson AL:
The intertwined fates of inflammation and coagulation in glioma.
Mamm Genome. 29:806–816. 2018. View Article : Google Scholar : PubMed/NCBI
|
